Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 2,045 $ 5,672
Short-term investments 17,854 10,836
Prepaid expenses and other current assets 38 54
Total Current Assets 19,937 16,562
Operating lease right-of-use asset 140 165
Deposits 9 9
TOTAL ASSETS 20,086 16,736
Current liabilities    
Accounts payable 3,131 3,140
Accrued expenses 829 1,669
Current operating lease liability 116 110
Total Current Liabilities 4,076 4,919
Non-current operating lease liability 31 64
Warrant liability 2,926 19
Total Liabilities 7,033 5,002
Stockholders’ Equity    
Convertible Preferred stock, par value $0.01, 15,000,000 shares authorized Series C - 96,230 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 1 1
Common stock, par value $0.001, 750,000,000 shares authorized, 36,303,218 shares and 32,061,989 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 37 33
Additional paid in capital 687,710 686,168
Accumulated deficit (674,695) (674,468)
Total Stockholders’ Equity 13,053 11,734
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 20,086 $ 16,736